Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3076204 | 0.79 | HDAC8 (0.52) | RAB9ANPC1ALDH1A1ALOX12LMNA | |
| SCHEMBL5527291 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL5515422 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL14823816 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL14823812 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL23192018 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL5511001 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL293980 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL5520084 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT | |
| SCHEMBL5525101 | 0.78 | HDAC8 (0.61) | ALDH1A1HDAC8HDAC6SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1007042-A4 | NOVEL HETEROARYL COMPOUNDS FOR THE MODULATION OF PROTEIN TYROSINE ENZYME RELATED CELLULAR SIGNAL TRANSDUCTION | SUGEN INC (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6143765-A | ENZYME IHIBITORS OF PROTEIN | SUGEN, INC. (US) | 2000-11-07 | — | — | US | disclosed |
| US-6080772-A | 2-AMINOTHIAZOLE TRIAZOLE OR TETRAZOLE COMPOUND FOR REGULATING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | SUGEN, INC. (US) | 2000-06-27 | — | — | US | disclosed |
| EP-1007042-A1 | NOVEL HETEROARYL COMPOUNDS FOR THE MODULATION OF PROTEIN TYROSINE ENZYME RELATED CELLULAR SIGNAL TRANSDUCTION | Sugen, Inc. (US) | 2000-06-14 | — | — | EP | disclosed |
| US-5883110-A | ORGANIC MOLECULES CAPABLE OF INHIBITING PROTEIN TYROSINE PHOSPHATASE ACTIVITY, AND THE USE OF SUCH MOLECULES TO TREAT VARIOUS DISEASE STATES INCLUDING DIABETES MELLITUS, GLIOMA, MELANOMA, KAPOSI'S SARCOMA, HEMANGIOMA, OVARIAN CANCER, BREAST | SUGEN, INC. (US) | 1999-03-16 | — | — | US | disclosed |
| WO-1998056376-A1 | NOVEL HETEROARYL COMPOUNDS FOR THE MODULATION OF PROTEIN TYROSINE ENZYME RELATED CELLULAR SIGNAL TRANSDUCTION | SUGEN, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| US-5798374-A | ADMINISTERING A 2-(5-NITROTHIAZOL-2-YL)MERCAPTO-1,2,4-TRIAZOLE DERIVATIVE TO TREAT VARIOUS DISEASE STATES INCLUDING DIABETES MELLITUS | SUGEN INC. (US) | 1998-08-25 | — | — | US | disclosed |
| WO-1998027092-A1 | THIAZOLE COMPOUNDS AND METHODS OF MODULATING SIGNAL TRANSDUCTION | SUGEN, INC. (US) | 1998-06-25 | — | — | WO | disclosed |